Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 113.02%50K | -17.82%-32.56M | -48.11%-9.82M | -45.59%-8.53M | -104.53%-13.82M | 95.42%-384K | 24.89%-27.63M | 19.10%-6.63M | 27.33%-5.86M | 38.55%-6.76M |
| Net income from continuing operations | 170.83%420K | -19.68%-36.26M | -37.62%-10.33M | -18.46%-9.37M | -95.30%-15.97M | 91.16%-593K | 14.35%-30.3M | -45.99%-7.5M | 16.29%-7.91M | 33.57%-8.18M |
| Operating gains losses | -9,988.89%-908K | -140.16%-400K | 248.76%180K | -266.23%-128K | -131.80%-443K | 97.45%-9K | 156.21%996K | -113.18%-121K | 119.54%77K | 176.83%1.39M |
| Depreciation and amortization | ---- | 17.08%1.14M | 1.44%282K | 6.90%279K | 26.91%283K | 40.00%294K | 59.08%972K | 74.84%278K | 76.35%261K | 59.29%223K |
| Remuneration paid in stock | -56.94%90K | -57.49%491K | -76.60%73K | -75.06%98K | -68.47%111K | 113.27%209K | 82.46%1.16M | 271.43%312K | 188.97%393K | 77.78%352K |
| Other non cashItems | -104.35%-7K | 463.37%969K | -17.54%47K | -27.94%49K | 1,171.43%712K | 1,888.89%161K | 104.13%172K | 101.30%57K | 106.88%68K | 450.00%56K |
| Change In working capital | 399.34%455K | 340.67%1.51M | -122.90%-79K | -56.32%549K | 296.86%1.19M | 90.64%-152K | -93.52%-627K | 110.07%345K | -49.54%1.26M | -121.58%-605K |
| -Change in receivables | -50.00%-6K | -105.80%-4K | 60.00%40K | -32.76%39K | -476.19%-79K | 88.57%-4K | 727.27%69K | 106.08%25K | -44.76%58K | -80.91%21K |
| -Change in prepaid assets | 137.50%6K | -177.66%-292K | -148.67%-73K | -53.77%49K | -189.68%-252K | 90.06%-16K | 30.10%376K | 63.04%150K | -40.45%106K | -41.58%281K |
| -Change in payables and accrued expense | 444.70%455K | 268.38%1.81M | -98.61%25K | 197.21%453K | 249.03%1.46M | 90.76%-132K | -195.32%-1.07M | 162.80%1.8M | -121.11%-466K | -144.26%-979K |
| -Change in other working capital | ---- | ---- | ---- | -99.49%8K | ---- | ---- | 654.39%1.33M | ---306K | --1.56M | ---- |
| Cash from discontinued investing activities | -348.71%-25.73M | -5.73M | ||||||||
| Operating cash flow | -319.73%-25.68M | -17.82%-32.56M | -48.11%-9.82M | -45.59%-8.53M | -19.67%-8.09M | 27.04%-6.12M | 31.59%-27.63M | 43.79%-6.63M | 27.33%-5.86M | 38.55%-6.76M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 173.24M | 79.57%-152K | -9.68%-34K | -164.29%-74K | 89.81%-44K | 0 | 6.53%-744K | 32.61%-31K | 94.26%-28K | -195.89%-432K |
| Net PPE purchase and sale | ---- | 79.57%-152K | -9.68%-34K | -164.29%-74K | 90.28%-42K | 99.21%-2K | 6.53%-744K | 32.61%-31K | 94.26%-28K | -195.89%-432K |
| Net business purchase and sale | --173.24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | -50.00%-3K | -2K | ||||||||
| Investing cash flow | 8,662,100.00%173.24M | 79.57%-152K | -9.68%-34K | -164.29%-74K | 90.28%-42K | 99.21%-2K | 6.53%-744K | 32.61%-31K | 94.26%-28K | -195.89%-432K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1,949.60%-133.13M | -48.17%20M | -102.33%-162K | 107.50%88K | 1,313.76%12.88M | -78.74%7.2M | 12.61%38.59M | -58.05%6.96M | -796.18%-1.17M | -105.84%-1.06M |
| Net issuance payments of debt | --0 | -208.71%-7.18M | -102.55%-179K | -32.89%-198K | -10,503.03%-14M | 5,204.96%7.2M | 146.43%6.6M | 25.37%7.02M | -69.32%-149K | 99.32%-132K |
| Net common stock issuance | ---135.14M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --2.08M | --677K | --64K | --366K | --247K | --0 | --0 | --0 | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | -322.32%-946K | 24.19%-47K | -11.29%-69K | -1,206.90%-758K | -71.43%-72K | 90.63%-224K | 83.98%-62K | -226.32%-62K | 97.04%-58K |
| Net other financing activities | ---73K | -14.80%27.45M | --0 | 98.86%-11K | ---- | ---- | -36.68%32.21M | --0 | -3,912.50%-963K | ---871K |
| Cash from discontinued financing activities | 1,318.49%3.23M | -265K | ||||||||
| Financing cash flow | -1,973.72%-129.91M | -48.17%20M | -102.33%-162K | 107.50%88K | 1,338.74%13.14M | -79.53%6.93M | 12.61%38.59M | -58.05%6.96M | -796.18%-1.17M | -105.84%-1.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -84.29%2.28M | 185.88%14.52M | -12.26%12.3M | -3.85%20.44M | -49.42%15.68M | 185.88%14.52M | -53.76%5.08M | 6,358.06%14.01M | 150.24%21.26M | 2,607.34%31M |
| Current changes in cash | 2,071.71%17.66M | -224.40%-12.71M | -3,485.14%-10.02M | -20.60%-8.51M | 160.79%5.02M | -96.78%813K | 247.63%10.21M | -93.76%296K | 18.67%-7.06M | -217.35%-8.25M |
| Effect of exchange rate changes | 429.02%1.84M | 160.59%469K | -97.58%5K | 296.26%367K | 83.14%-251K | -49.93%348K | -176.26%-774K | 76.92%207K | -146.75%-187K | -563.86%-1.49M |
| End cash Position | 38.91%21.78M | -84.29%2.28M | -84.29%2.28M | -12.26%12.3M | -3.85%20.44M | -49.42%15.68M | 185.88%14.52M | 185.88%14.52M | 6,358.06%14.01M | 150.24%21.26M |
| Free cash from | -319.73%-25.68M | -15.26%-32.71M | -47.93%-9.86M | -46.15%-8.6M | -13.09%-8.13M | 29.17%-6.12M | 31.10%-28.38M | 43.74%-6.66M | 31.15%-5.89M | 35.48%-7.19M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.